未登录
分享
收藏Anbenitamab in combination with chemotherapy in patients with HER2-positive gastric or gastroesophageal junction carcinoma who failed previous therapy containing trastuzumab: a multicenter, phase II study (KC-WISE 01)阿本替尼(anbenitamab)联合化疗用于既往接受过含曲妥珠单抗(trastuzumab)治疗失败的HER2阳性胃或胃食管结合部癌患者的治疗:一项多中心、II期研究(KC-WISE 01)。
Zhao, Chuanhua; Zhao, Jun; Chen, Yigui; Liu, Bo; Du, Yangfeng; Li, Chenglin; Zhang, Jingdong; Yang, Mudan; Liu, Ying; Bai, Yuxian; Li, Suyi; Zhang, Ruixing; Ning, Fangling; Liu, Yanping; Zou, Kai; Zhang, Qi; Xie, Yijiao; An, Yuping; Xu, Jianming
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trialIparomlimab (QL1604) 在微卫星不稳定性高 (msi-h) 或错配修复缺陷 (dMMR) 不可切除或转移性实体瘤患者中的应用: 一项关键的单臂多中心II期试验
Bi, Feng; Dong, Jian; Jin, Chuan; Niu, Zuoxing; Yang, Wenhui; He, Yifu; Yu, Dajun; Sun, Meili; Wang, Teng; Yin, Xianli; Zhang, Ruixing; Chen, Kehe; Wang, Keming; Wang, Zhiwu; Li, Wei; Zhang, Zhongtao; Zhang, Hangyu; Guo, Qunyi; Wang, Xin; Han, Lei; Zhang, Xizhi; Shen, Wei; Zhang, Liangming; Ying, Jieer; Wu, Miao; Hu, Weiguo; Li, Zeng; Li, Xiaofen; Feng, Wenlei; Zhang, Baihui; Li, Lingyan; Kang, Xiaoyan; Guo, Weijian
分享
收藏
分享
收藏
分享
收藏Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialTislelizumab加化疗与安慰剂加化疗作为晚期胃或胃食管交界处腺癌的一线治疗: 原理305的随机,双盲,3期试验
Qiu, Miao-Zhen; Oh, Do-Youn; Kato, Ken; Arkenau, Tobias; Tabernero, Josep; Correa, Marcia Cruz; Zimina, Anastasia, V; Bai, Yuxian; Shi, Jianhua; Lee, Keun-Wook; Wang, Jufeng; Poddubskaya, Elena; Pan, Hongming; Rha, Sun Young; Zhang, Ruixing; Hirano, Hidekazu; Spigel, David; Yamaguchi, Kensei; Chao, Yee; Wyrwicz, Lucjan; Disel, Umut; Cid, Roberto Pazo; Fornaro, Lorenzo; Evesque, Ludovic; Wang, Hongwei; Xu, Yaling; Li, Jiang; Sheng, Tao; Yang, Silu; Li, Liyun; Moehler, Markus; Xu, Rui-Hua
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review
Geng, Dandan; Wang, Yingnan; Zhang, Xin; Zhao, Chenguang; Fan, Yao; Liu, Chang; Wei, Jinmei; Huo, Bingjie; Zhao, Yang; Zhang, Fengbin; Zhang, Ruixing
分享
收藏
分享
收藏
分享
收藏Prevalence of delirium, depression, anxiety, and post-traumatic stress disorder among COVID-19 patients: protocol for a living systematic reviewCOVID-19患者的谵妄,抑郁,焦虑和创伤后应激障碍的患病率: 生活系统评价的方案
Shi, Jiyuan; Gao, Ya; Zhao, Liang; Li, Yuanyuan; Yan, Meili; Niu, Ming Ming; Chen, Yamin; Song, Ziwei; Zhang, Ruixing; Zhang, Lili; Tian, Jinhui
分享
收藏An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)
Wang, Xiang; Zhang, Ruixing; Du, Nan; Yang, Mudan; Zang, Aimin; Liu, Likun; Yu, Junyan; Gao, Jinghua; Zhang, Junping; Fu, Zhanzhao; Ren, Yuchuan; Ma, Liwen; Guo, Jun; Li, Qingshan; Li, Xiaomei; Fan, Zaiwen; Song, Xiang; Liu, Zheng; Zhang, Yan; Li, Guozhong; Yu, Zhonghe; Diao, Jianfeng; Jia, Junmei; Liang, Feng; Wang, Huaqing; Sun, Junzhong; Gao, Yunge; Yang, Ping; Bai, Chunmei; Ren, Xiubao; Zhong, Diansheng
分享
收藏
分享
收藏